Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma.
Maldonado-Pérez N, Tristán-Manzano M, Justicia-Lirio P, Martínez-Planes E, Muñoz P, Pavlovic K, Cortijo-Gutiérrez M, Blanco-Benítez C, Castella M, Juan M, Wenes M, Romero P, Molina-Estévez FJ, Marañón C, Herrera C, Benabdellah K, Martin F.
Maldonado-Pérez N, et al. Among authors: munoz p.
Front Immunol. 2022 Oct 6;13:1011858. doi: 10.3389/fimmu.2022.1011858. eCollection 2022.
Front Immunol. 2022.
PMID: 36275777
Free PMC article.